Cargando…

Quality control of cervical cytology using a 3-type HPV mRNA test increases screening program sensitivity of cervical intraepithelial neoplasia grade 2+ in young Norwegian women—A cohort study

Within 2021, Norway intends to complete implementation of HPV DNA-based primary screening for cervical cancer for women 34–69 years, while continue cytology-based screening for women 25–33 years. Over the recent years, the incidence of cervical cancer has increased by 30% among women younger than 40...

Descripción completa

Detalles Bibliográficos
Autores principales:	Westre, Bjørn, Giske, Anita, Guttormsen, Hilde, Wergeland Sørbye, Sveinung, Skjeldestad, Finn Egil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830931/ https://www.ncbi.nlm.nih.gov/pubmed/31689301 http://dx.doi.org/10.1371/journal.pone.0221546

Ejemplares similares

5-type HPV mRNA versus 14-type HPV DNA test: test performance, over-diagnosis and overtreatment in triage of women with minor cervical lesions
por: Westre, Bjørn, et al.
Publicado: (2016)

May Women with a Negative Co-Test at First Follow-Up Visit Return to 3-Year Screening after Treatment for Cervical Intraepithelial Neoplasia?
por: Skjeldestad, Finn Egil, et al.
Publicado: (2023)

Risk of Intraepithelial Neoplasia Grade 3 or Worse (CIN3+) among Women Examined by a 5-Type HPV mRNA Test during 2003 and 2004, Followed through 2015
por: Rad, Amir, et al.
Publicado: (2023)

HPV mRNA Is More Specific than HPV DNA in Triage of Women with Minor Cervical Lesions
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2014)

Primary cervical cancer screening with an HPV mRNA test: a prospective cohort study
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2016)

13-Type HPV DNA Test versus 5-Type HPV mRNA Test in Triage of Women Aged 25–33 Years with Minor Cytological Abnormalities–6 Years of Follow-Up
por: Rad, Amir, et al.
Publicado: (2023)

HPV types in cervical cancer tissue in South Africa: A head-to-head comparison by mRNA and DNA tests
por: Rad, Amir, et al.
Publicado: (2017)

Risk of cervical intraepithelial neoplasia grade 3 or higher (CIN3+) among women with HPV-test in 1990–1992, a 30-year follow-up study
por: Riibe, Marit Østlyngen, et al.
Publicado: (2021)

Triage of Women with Low-Grade Cervical Lesions - HPV mRNA Testing versus Repeat Cytology
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2011)

Detection of High-Grade Cervical Intraepithelial Neoplasia by Electrical Impedance Spectroscopy in Women Diagnosed with Low-Grade Cervical Intraepithelial Neoplasia in Cytology
por: Panagakis, Georgios, et al.
Publicado: (2023)

High prevalence of HPV16 and high‐grade cytology in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2
por: Damgaard, Rikke Kamp, et al.
Publicado: (2023)

HPV type-related chromosomal profiles in high-grade cervical intraepithelial neoplasia
por: Bierkens, Mariska, et al.
Publicado: (2012)

Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirusesting
por: Carozzi, F, et al.
Publicado: (2000)

HIV-Infected Women with Low-Grade Squamous Intraepithelial Lesion on Cervical Cytology Have Higher Risk of Underlying High-Grade Cervical Intraepithelial Neoplasia
por: Sakdadech, Nawin, et al.
Publicado: (2021)

Genotype-specific methylation of HPV in cervical intraepithelial neoplasia
por: Hsu, Yaw-Wen, et al.
Publicado: (2017)

HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology
por: Lorincz, Attila T, et al.
Publicado: (2013)

Cytology-based Screening for Anal Intraepithelial Neoplasia in Immunocompetent Brazilian Women with a History of High-Grade Cervical Intraepithelial Neoplasia or Cancer
por: Brum, Vivian de Oliveira Rodrigues, et al.
Publicado: (2022)

Impact of HPV mRNA types 16, 18, 45 detection on the risk of CIN3+ in young women with normal cervical cytology
por: Al-Shibli, Khalid, et al.
Publicado: (2022)

HPV E6/E7 mRNA Testing Is More Specific than Cytology in Post-Colposcopy Follow-Up of Women with Negative Cervical Biopsy
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2011)

Human papillomavirus status in the prediction of high-grade cervical intraepithelial neoplasia in patients with persistent low-grade cervical cytological abnormalities.
por: Herrington, C. S., et al.
Publicado: (1995)

Persistent HPV-16 infection leads to recurrence of high-grade cervical intraepithelial neoplasia
por: Byun, Jung Mi, et al.
Publicado: (2018)

HPV 16 Is Related to the Progression of Cervical Intraepithelial Neoplasia Grade 2: A Case Series
por: Loffredo D'Ottaviano, Maria Gabriela, et al.
Publicado: (2013)

A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia
por: Mariano, Vânia Sammartino, et al.
Publicado: (2016)

Diagnostic Value of the Care™ HPV Test in Screening for Cervical Intraepithelial Neoplasia Grade 2 or Worse
por: Zarchi, Mojgan Karimi, et al.
Publicado: (2017)

Cervical Intraepithelial Neoplasia Grade 3 in a HPV-Vaccinated Patient: A Case Report
por: Sladič, Mateja, et al.
Publicado: (2022)

Cervical intraepithelial neoplasia in lymphoma patients: a cytological and colposcopic study.
por: Hughes, R. G., et al.
Publicado: (1989)

Methylation of CADM1 and MAL together with HPV status in cytological cervical specimens serves an important role in the progression of cervical intraepithelial neoplasia
por: Meršaková, Sandra, et al.
Publicado: (2018)

Cytology and Human Papillomavirus Co-Test Results Preceding Incident High-Grade Cervical Intraepithelial Neoplasia
por: Park, Ina U., et al.
Publicado: (2015)

Clinical impact of age‑specific distribution of combination patterns of cytology and high‑risk HPV status on cervical intraepithelial neoplasia grade 2 or more
por: Sakai, Mie, et al.
Publicado: (2023)

Risk of HPV-related extra-cervical cancers in women treated for cervical intraepithelial neoplasia
por: Preti, Mario, et al.
Publicado: (2020)

Clinical analysis of cervical intraepithelial neoplasia with vaginal intraepithelial neoplasia
por: He, Yue, et al.
Publicado: (2017)

Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women
por: Muñoz, N, et al.
Publicado: (2009)

Trend of HPV 16/18 Genotypes in Cervical Intraepithelial Neoplasia Grade 3: Data for 2007–2018
por: Giannella, Luca, et al.
Publicado: (2021)

Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia
por: Hosseini, Maryam Sadat, et al.
Publicado: (2018)

Clinical and Pathological Heterogeneity of Cervical Intraepithelial Neoplasia Grade 3
por: Yang, Hannah P., et al.
Publicado: (2012)

Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England
por: Howell-Jones, R, et al.
Publicado: (2010)

Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England
por: Howell-Jones, R, et al.
Publicado: (2010)

Cervical intraepithelial neoplasia in patients with breast cancer: a cytological and colposcopic study.
por: Hughes, R. G., et al.
Publicado: (1993)

Prevalance of abnormal vault cytology after hysterectomy for cervical intraepithelial neoplasia, Pietermaritzburg
por: Mbuyisa, Sanele S., et al.
Publicado: (2022)

Triage of Women with Minor Cervical Lesions: Data Suggesting a “Test and Treat” Approach for HPV E6/E7 mRNA Testing
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_uk51kq7ov54pi7uikme6hg83h9